⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Bavarian Nordic A/S and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Bavarian Nordic A/S
↗Hellerup, Denmark
Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing, and commercialization of life-saving vaccines for infectious diseases and cancer immunotherapies. The company is a global leader in public preparedness, supplying vaccines for mpox and smallpox to governments and international organizations worldwide.
Headquartered in Denmark, the company has evolved over three decades from an R&D-focused entity into a commercial-stage powerhouse. Its portfolio includes travel vaccines and public health preparedness solutions, with recent expansions into chikungunya and other infectious disease areas.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1001-5000
Revenue:$800M-$900M
Founded:1994
Ownership:public
Status:operating
STOCK
Exchange:Nasdaq Copenhagen
Ticker:BAVA
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Recombinant vector vaccine, VLP (Virus-Like Particle)
Active Trials:0
Trial Phases:-
FDA Approvals:2
EMA Approvals:2
CORPORATE STRUCTURE
Subsidiaries:Bavarian Nordic Inc., Bavarian Nordic GmbH
Key Partnerships:Serum Institute of India (Chikungunya manufacturing), Janssen (Vaccine development collaborations)
COMPETITION
Position:Leader
Competitors:Pfizer, GSK, Sanofi, Emergent BioSolutions
LEADERSHIP
Key Executives:
Paul Chaplin - CEO (Exiting 2026)
LINKS
Website:bavarian-nordic.com
LinkedIn:LinkedIn Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Bavarian Nordic A/S. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.